Decreased expression of microtubule-associated protein 5 (MAP5) in the molecular layer of cerebellum in preterm infants with olivocerebellar lesions.
The changes in microtubule-associated protein 5 (MAP5) expression in the cerebellum with olivocerebellar degeneration (OCD) were investigated by means of immunohistochemical method, compared with gestational age-matched controls. In controls of 24-33 postmenstrual weeks, the molecular layer was diffusely immunoreactive. However, in cases of olivocerebellar degeneration (25-35 postmenstrual weeks), MAP5 immunoreactivity was reduced in the inner half of the molecular layer, especially in a portion where Purkinje cells were absent. The ratio of the density in the outer half of the molecular layer to that in the inner half was also determined with an image analyzer, and increased significantly in Purkinje cell-negative areas. Because MAP5 was believed to be expressed mainly on growing axons in the early fetal period, the reduction of MAP5 immunoreactivity in OCD cases suggested that normal interaction of Purkinje cells and climbing fibers is vulnerable to ischemia and hypoxia in developing stage and that retrograde transynaptic degeneration of the inferior olivary nuclei is secondarily induced.
Ohyu
J
J
Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, Japan. ohyu@ncnaxp.ncnp.go.jp
Takashima
S
S
D001927:Brain Diseases / Q000378:metabolism; D002526:Cerebellar Diseases / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism*; D005865:Gestational Age; D006801:Humans; D007150:Immunohistochemistry; D007231:Infant, Newborn; D007234:Infant, Premature / Q000378:metabolism*; D008869:Microtubule-Associated Proteins / Q000378:metabolism*; D009847:Olivary Nucleus; D012016:Reference Values; D014018:Tissue Distribution
D008869:Microtubule-Associated Proteins; C085284:microtubule-associated protein 1B